Product Images Fenofibrate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Fenofibrate NDC 46708-361 by Alembic Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fenofibrate-145-mg.jpg - fenofibrate 145 mg

fenofibrate-145-mg.jpg - fenofibrate 145 mg

This is a description of a medication called "E@pofibrate". The medication comes in tablet form and should be stored at controlled room temperature to protect it from moisture. The bottle should not be accepted if the seal is broken or missing. It should be dispensed in a USP fight container. The medication is manufactured by Alembic Pharmaceuticals Limited, located in India. The text also includes the Rx number, which is 46708-361-30 and the quantity which is 30 tablets.*

fenofibrate-48-mg.jpg - fenofibrate 48 mg

fenofibrate-48-mg.jpg - fenofibrate 48 mg

Each tablet of this medication contains 28mg of Fenofibrate, a medicine used to lower high cholesterol and triglyceride levels in the blood. The recommended dosage should be consulted from the package insert. It is advised to store the medicine in a cool, dry place below 30°C and protect it from moisture. The manufacturer is Alembic Pharmaceuticals Limited located in Gujarat, India. The medication comes in a bottle of 30 tablets that should be dispensed in a USP tight container. The NDC number of this medication is 46708-360-30. The lot number and manufacturing license number are also provided.*

Structure - fenofibrate structure

Structure - fenofibrate structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.